NEW YORK (Thomson Financial) - Uroplasty Inc. Tuesday said its 1.5 million
share public offering had been priced at $3.50 a share, below its Monday closing
price of $3.96.
Craig-Hallum Capital Group was listed as bookrunning lead manager in the
offering. The company granted underwriters an option to buy roughly 220,000
additional shares to cover any over allotment.
Uroplasty, a Minneapolis-based manufacturer of voiding dysfunctions
treatment products, said it would use the proceeds from the offering to expand
its sales and marketing organizations and to conduct clinical studies.
Shares of Uroplasty rose 6 cents to $4.02 on Tuesday.
Ryan Vlastelica
rv/pc
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|